scholarly journals Effect of Vitamin D3Supplementation on Improving Glucose Homeostasis and Preventing Diabetes: A Systematic Review and Meta-Analysis

2014 ◽  
Vol 99 (10) ◽  
pp. 3551-3560 ◽  
Author(s):  
Jennifer C. Seida ◽  
Joanna Mitri ◽  
Isabelle N. Colmers ◽  
Sumit R. Majumdar ◽  
Mayer B. Davidson ◽  
...  
Medicine ◽  
2017 ◽  
Vol 96 (48) ◽  
pp. e8719 ◽  
Author(s):  
Sandra Korol ◽  
Fannie Mottet ◽  
Sylvie Perreault ◽  
William L. Baker ◽  
Michel White ◽  
...  

2019 ◽  
Vol 122 (04) ◽  
pp. 376-387 ◽  
Author(s):  
J. Zhu ◽  
P. Xun ◽  
J. C. Bae ◽  
J. H. Kim ◽  
D. J. Kim ◽  
...  

AbstractAbnormal Ca homeostasis has been associated with impaired glucose metabolism. However, the epidemiological evidence is controversial. We aimed to assess the association between circulating Ca levels and the risk of type 2 diabetes mellitus (T2DM) or abnormal glucose homeostasis through conducting a systematic review and meta-analysis. Eligible studies were identified by searching electronic database (PubMed, Embase and Google Scholar) and related references withde novoresults from primary studies up to December 2018. A random-effects meta-analysis was performed to estimate the weighted relative risks (RR) and 95 % CI for the associations. The search yielded twenty eligible publications with eight cohort studies identified for the meta-analysis, which included a total of 89 165 participants. Comparing the highest with the lowest category of albumin-adjusted serum Ca, the pooled RR was 1·14 (95 % CI 1·05, 1·24) for T2DM (n51 489). Similarly, serum total Ca was associated with incident T2DM (RR 1·25; 95 % CI 1·10, 1·42) (n64 502). Additionally, the adjusted RR for 1 mg/dl increments in albumin-adjusted serum Ca or serum total Ca levels was 1·16 (95 % CI 1·07, 1·27) and 1·19 (95 % CI 1·11, 1·28), respectively. The observed associations remained with the inclusion of a cohort study with ionised Ca as the exposure. However, data pooled from neither case–control (n4) nor cross-sectional (n8) studies manifested a significant correlation between circulating Ca and glucose homeostasis. In conclusion, accumulated data from the cohort studies suggest that higher circulating Ca levels are associated with an augmented risk of T2DM.


2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Sepideh Alasvand ◽  
WIlliam Bridges ◽  
Vivian Haley-Zitlin

Abstract Objectives A meta-analysis systematic review that investigates the impact of the herbal tea (non-camellia sinensis) on glucose homeostasis and serum lipids in individuals with type 2 diabetes was conducted in response to a growing interest in herbal remedies as a potential alternative source of management of type 2 diabetes. Diabetes mellitus (DM) is a metabolic disorder that has contributed to the US burden of morbidity, disability and mortality with a fast-increasing global trend through the last decades. Methods PubMed, FSTA, Web of Science, CINAHEL and MEDLINE databases were searched using keywords diabetes* OR “diabetes mellitus” OR “type 2” OR “blood glucose” OR insulin* OR antidiabet* OR “glucose level”) AND (“Serum lipids” OR triglyceride* OR cholesterol* OR “LDL” OR “HDL” OR dyslipidemia) AND (“non-camellia sinensis” OR tea) up to January 2019. Review articles, animal studies, non-trial, non-herbal tea (green, black and white tea), and articles which did not evaluate glucose homeostasis and lipid profiles were included in the exclusion criteria. Articles that met the inclusion criteria included herbal tea administration effects on glucose homeostasis and serum lipids in clinical trials. All statistical calculations were performed using SAS software version 9.2 (SAS, Cary NC, USA). Results From 265 studies eight trials were included in the meta-analysis of glycemic and serum lipid profile end points. According to meta-analysis outputs, the estimated value for pooled fasting blood glucose (FBG) was −6.17 mg/dl, 95% CI: −19.96 to 7.6054, p value = 0.37; HbA1c (2.70, 95% CI: −1.1 to 6.5, p = 0.1), total-cholesterol (TC) (−10.896 mg/dl, 95% CI: −65.68 to 43.88, p = 0.69), LDL-cholesterol (LDL) (−8.57 mg/dl, 95% CI: −22.42 to 5.27, p = 0.22). The overall effects for triglyceride (TG) (−24.18 mg/dl, 95% CI: −42.69 to −5.68, p = 0.01) was significantly reduced by tea administration and HDL-cholesterol (HDL) (2.823 mg/dl, 95% CI: 9.7866 to 15.433 p = 0.05) significantly increased in the meta-analysis study. Conclusions The systematic review and meta-analysis supports a significant effect of herbal tea on triglyceride levels and HDL levels in individuals with type 2 diabetes. Additional clinical trials with a larger number of participants are needed as the number of studies is limited. Funding Sources N/A.


2018 ◽  
Vol 9 (6) ◽  
pp. 726-740 ◽  
Author(s):  
Marija Glisic ◽  
Natyra Kastrati ◽  
Valentina Gonzalez-Jaramillo ◽  
Wichor M Bramer ◽  
Fariba Ahmadizar ◽  
...  

2019 ◽  
Author(s):  
Manawa Diwekar-Joshi ◽  
Milind Watve

AbstractRecent work has suggested that altered insulin signalling may not be central and as critical to the pathophysiology of type 2 diabetes as classically believed. We critically re-examine the role of insulin in glucose homeostasis using five different approaches namely (i) systematic review and meta-analysis of tissue specific insulin receptor knock-out experiments in rodents, (ii) systematic review and meta-analysis of insulin suppression and insulin enhancement experiments in rodents and humans, (iii) differentiating steady-state and post-meal state glucose levels in streptozotocin treated rats in primary experiments (iv) mathematical and theoretical considerations and (v) glucose insulin relationship in human epidemiological data. All the approaches converge on the inference that although insulin action is needed to reach a homeostatic steady-state of glucose in fasting condition, there is no evidence that insulin action determines the steady-state level of glucose. A wider scale implication of the analysis is in emphasizing the need to differentiate steady state causality from perturbed state causality or on a broader scale driver causality from navigator causality in biology. A driver cause is a factor which is necessary to attain a destination but does not by itself decide the destination. A navigator cause, on the other hand, is one which by itself may not be sufficient to drive the system to a destination but which plays a role in deciding the destination or direction. Insulin appears to be a driver but not a navigator for glucose homeostasis. All evidence suggests that insulin action is required for reaching a homeostatic steady state, but it does not determine the steady-state level of glucose.


2020 ◽  
Vol 223 ◽  
pp. 2-8 ◽  
Author(s):  
Błażej Misiak ◽  
Michał Wiśniewski ◽  
Michał Lis ◽  
Jerzy Samochowiec ◽  
Bartłomiej Stańczykiewicz

2018 ◽  
Vol 15 (1) ◽  
Author(s):  
Cindy Le Bourgot ◽  
Emmanuelle Apper ◽  
Sophie Blat ◽  
Frédérique Respondek

Sign in / Sign up

Export Citation Format

Share Document